Gene · 7980
Papers2,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic targets for hepatocellular carcinoma identified using proteomics and Mendelian randomization. | J Gastroenterol Hepatol | 2025 | 39477889 | PubTator, text mining | PubMed |
| Steroids and Malignancy Increase Local Heparanase and Decrease Markers of Osteoblast Activity in Bone Tissue Microcirculation. | Biomolecules | 2024 | 39766213 | PubTator, text mining | PubMed |
| Extensive methylation analysis of circulating tumor DNA in plasma of patients with gastric cancer. | Sci Rep | 2024 | 39730450 | PubTator, text mining | PubMed |
| Detection of a novel DNA methylation marker panel for esophageal cancer diagnosis using circulating tumor DNA. | BMC Cancer | 2024 | 39725880 | PubTator, text mining | PubMed |
| Correction: Downregulated DUXAP8 lncRNA impedes trophoblast cell proliferation and migration by epigenetically upregulating TFPI2 expression. | Reprod Biol Endocrinol | 2024 | 39716218 | PubTator, text mining | PubMed |
| Hypothermic oxygenated perfusion inhibits CLIP1-mediated TIRAP ubiquitination via TFPI2 to reduce ischemia‒reperfusion injury of the fatty liver. | Exp Mol Med | 2024 | 39617791 | PubTator, text mining | PubMed |
| Structural and Functional Insights into Dishevelled-Mediated Wnt Signaling. | Cells | 2024 | 39594618 | PubTator, text mining | PubMed |
| Tissue factor pathway inhibitor 2 (TFPI2) is a potential serum biomarker for clear cell renal carcinoma. | Sci Rep | 2024 | 39562727 | PubTator, text mining | PubMed |
| Applications of CRISPR Technologies in Forestry and Molecular Wood Biotechnology. | Int J Mol Sci | 2024 | 39519342 | PubTator, text mining | PubMed |
| Acoustic emission monitoring of damage modes in reinforced concrete beams by using narrow partial power bands. | Sci Rep | 2024 | 39511281 | PubTator, text mining | PubMed |
| High-glucose impact on UVB responses in human epidermal keratinocytes: Insights on diabetic skin's resistance to photocarcinogenesis. | Life Sci | 2024 | 39343088 | PubTator, text mining | PubMed |
| Identification of new subtypes of breast cancer based on vasculogenic mimicry related genes and a new model for predicting the prognosis of breast cancer. | Heliyon | 2024 | 39263085 | PubTator, text mining | PubMed |
| Inhibition of the AP-1/TFPI2 axis contributes to alleviating cerebral ischemia/reperfusion injury by improving blood-brain barrier integrity. | Hum Cell | 2024 | 39227518 | PubTator, text mining | PubMed |
| Plasma microRNA Environment Linked to Tissue Factor Pathway and Cancer-Associated Thrombosis: Prognostic Significance in Ovarian Cancer. | Biomolecules | 2024 | 39199316 | PubTator, text mining | PubMed |
| A high-calcium environment induced ectopic calcification of renal interstitial fibroblasts via TFPI-2-DCHS1-ALP/ENPP1 axis to participate in Randall's plaque formation. | Urolithiasis | 2024 | 39196305 | PubTator, text mining | PubMed |
| Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study. | BMC Cancer | 2024 | 39192208 | PubTator, text mining | PubMed |
| Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer. | Cancer Lett | 2024 | 39154703 | PubTator, text mining | PubMed |
| Tissue factor pathway inhibitor-2 (TFPI-2)-an underappreciated partaker in cancer and metastasis. | Cancer Metastasis Rev | 2024 | 39153052 | PubTator, text mining | PubMed |
| Unveiling heterogeneity and prognostic markers in ductal breast cancer through single-cell RNA-seq. | Cancer Cell Int | 2024 | 39068476 | PubTator, text mining | PubMed |
| Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinoma. | NPJ Precis Oncol | 2024 | 38851780 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7980/papers?page=4